Free Trial
LON:MHC

MyHealthChecked (MHC) Share Price, News & Analysis

MyHealthChecked logo
GBX 18.76 +0.26 (+1.41%)
As of 04:06 AM Eastern

About MyHealthChecked Stock (LON:MHC)

Key Stats

Today's Range
18
18.76
50-Day Range
10.50
18.17
52-Week Range
8
19.19
Volume
175,369 shs
Average Volume
119,172 shs
Market Capitalization
£9.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests. MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Receive MHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MyHealthChecked and its competitors with MarketBeat's FREE daily newsletter.

MHC Stock News Headlines

Did You See Trump’s Manhattan Project Bombshell?
This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House. Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)... Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years.
Oberon AIM VCT Ord (OVCT.L)
Returns At MyHealthChecked (LON:MHC) Are On The Way Up
See More Headlines

MHC Stock Analysis - Frequently Asked Questions

MyHealthChecked's stock was trading at GBX 12.50 at the beginning of 2025. Since then, MHC shares have increased by 50.1% and is now trading at GBX 18.76.
View the best growth stocks for 2025 here
.

Shares of MHC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that MyHealthChecked investors own include Beowulf Mining (BEM), B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Gresham House Strategic (GHS) and Greencore Group (GNC).

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

Net Income
£-1,040,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£9.39 million
Cash Flow
GBX 10.22 per share
Book Value
GBX 14 per share

Miscellaneous

Free Float
N/A
Market Cap
£9.45 million
Optionable
Not Optionable
Beta
1.37
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (LON:MHC) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners